Marissa Elizabeth Bernstein

Marissa Bernstein practices at Sturdy Memorial Hospital in Attleboro, Massachusetts, part of Sturdy Health.

Marissa Bernstein's NPI, 1467895771, was assigned on April 17, 2013. Marissa Bernstein holds Massachusetts license 266457.

Marissa Bernstein's primary practice is Sturdy Memorial Hospital, at 211 Park Street, Attleboro, MA 02703 in Bristol County. The practice phone is (508) 222-5200.

Marissa Bernstein's primary practice is Sturdy Memorial Hospital in Attleboro, Massachusetts, part of Sturdy Health. The medical group on file is Sturdy Health Hematology & Oncology. Dmand AI also links Marissa Bernstein to 1 more breast imaging center and 1 imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Marissa Bernstein practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Marissa Bernstein's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Marissa Bernstein is licensed in Massachusetts.

CMS data shows 1,037 Medicare services from Marissa Bernstein across 6 procedure codes in 2024, for 356 Medicare patients. Medicare paid $65,259 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 356 Medicare patients who saw Marissa Bernstein in 2024. The largest group is 75 to 84, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Marissa Bernstein's median patient age at 76, with 56% women.

In 2024, Marissa Bernstein wrote 290 Medicare Part D claims for 155 patients. 89% of them were for generic drugs. CMS names the drug for 101 of them, across 7 drugs with 11 or more claims each, at $8,163 in total drug cost. In 2023, CMS named 53 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Marissa Bernstein for performance year 2024, reported as part of a group. Marissa Bernstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Marissa Bernstein from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $13.